The structure of bicyclomycin, a novel antibiotic, was largely elucidated by nuclear magnetic resonance spectroscopy and established finally as 8, 10-diaza-6-hydroxy-5-methylene-l-(2'-methyl-1', 2', 3'-trihydroxy-propyl)-2-oxabicyclo [4, 2, 2] decan-7, 9-dione by X-ray crystallographic diffraction analysis. A number of its acyl derivatives were prepared and studied biologically. The relationship between the structure of the acyl derivatives and the rate of urinary excretion was also examined.
No takes yet. Share an insight, caveat, or question.
Kamiya et al. (1972) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: